B-cell malignancies and differentiation antigens defined with monoclonal antibodies. 1983

K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede

Monoclonal antibodies directed to B-cell lineage were produced. They were characterized by their reactivity with a variety of human hematopoietic cell lines and normal lymphoid cells and by the immunohistological distribution of cells positive for the antibodies. Some of them were specific for B-cell lineage at various stages of B-cell differentiation and some were, in addition, cross-reactive with other cell lineages. These newly produced antibodies were utilized to dissect and characterize B-cell malignancies and were applied for classification of B-cell malignancies.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000944 Antigens, Differentiation, B-Lymphocyte Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin. Antigens, Differentiation, B-Cell,B-Cell Differentiation Antigens,B-Lymphocyte Differentiation Antigens,Blast-2 Antigen, B-Cell,Differentiation Antigens, B-Cell,Differentiation Antigens, B-Lymphocyte,Leu Antigens, B-Lymphocyte,Plasma Cell Antigens PC-1,Antigens, Differentiation, B Lymphocyte,Antigens, Plasma Cell, PC-1,B-Cell Blast-2 Antigen,Antigen, B-Cell Blast-2,Antigens, B-Cell Differentiation,Antigens, B-Lymphocyte Differentiation,Antigens, B-Lymphocyte Leu,B Cell Blast 2 Antigen,B Cell Differentiation Antigens,B Lymphocyte Differentiation Antigens,B-Lymphocyte Leu Antigens,Blast 2 Antigen, B Cell,Differentiation Antigens, B Cell,Differentiation Antigens, B Lymphocyte,Leu Antigens, B Lymphocyte,Plasma Cell Antigens PC 1
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell

Related Publications

K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
October 1987, Laboratory investigation; a journal of technical methods and pathology,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
February 1982, Proceedings of the National Academy of Sciences of the United States of America,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
January 1981, Immunogenetics,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
December 1984, Cell differentiation,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
August 1981, Proceedings of the National Academy of Sciences of the United States of America,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
January 1988, Anticancer research,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
October 1994, Veterinary immunology and immunopathology,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
December 1986, Asian Pacific journal of allergy and immunology,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
May 1997, Veterinary immunology and immunopathology,
K Kikuchi, and H Koshiba, and K Kasai, and H Hiratsuka, and N Fujimoto, and T Uede
November 1984, Brain research,
Copied contents to your clipboard!